Riskpilot← Back to searchSign inGet full accessAUBERGINE AS
ASActiveOrg 918569308Chr. Jensens Vei 2, 1390 VollenOther human health activities n.e.c. · NACE 8699Est. 20170 employees
Revenue 2024
NOK 726K
+137% vs 2023
EBITDA margin
73.5%
+152% vs 2023
Equity ratio
30.6%
Financial strength
Net profit 2024
NOK 3,9M
+1975% vs 2023
| Revenue | NOK 726K | +137% |
| EBITDA | NOK 534K | +152% |
| Net profit | NOK 3,9M | +1975% |
| Total assets | NOK 14,9M | +119% |
| Equity | NOK 4,6M | +626% |
| Employees | 0 | — |
Legal name
AUBERGINE AS
Org number
918569308
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
15. februar 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utføre alle former for tjenesteyting innenfor helse og omsorgssektoren, samt drive handel som har tilknytning til tjenesteyting. Selskapet skal også kunne drive annen forretningsvirksomhet av enhver art, herunder formidling, kjøp og salg av varer og tjenester. Selskapet skal også investere i fast eiendom, aksjer, verdipapirer, herunder deltagelse i andre selskaper, samt plassering av likvid kapital på en sikker og regningsvarende måte.
Address
Chr. Jensens Vei 2, 1390 Vollen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 181 | 508 | 504 | 306 | 726 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 170 | 190 | −603 | 212 | 534 |
| Depreciation & amort. | −0 | −0 | −19 | −22 | −22 |
| EBIT | 170 | 190 | −622 | 190 | 511 |
| Net financials | 624 | −1 265 | 640 | −0 | 3 287 |
| Profit before tax | 794 | −1 074 | 19 | 189 | 3 798 |
| Tax | 38 | 42 | −6 | −0 | −133 |
| Net profit | 757 | −1 116 | 24 | 189 | 3 931 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 992 | 6 151 | 6 396 | 6 817 | 14 916 |
| Equity | 1 531 | 414 | 439 | 628 | 4 559 |
| Long-term debt | 0 | 4 806 | 4 800 | 4 925 | 10 072 |
| Short-term debt | 462 | 931 | 1 157 | 1 264 | 285 |
| Total debt | 462 | 5 736 | 5 957 | 6 189 | 10 357 |
EBITDA margin
73.5%
This company
15.8%
Market median
+365% vs market
20202024
Equity ratio
30.6%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
86.2%
This company
18.4%
Market median
+368% vs market
20202024
Net profit margin
541.2%
This company
8.1%
Market median
+6581% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
2.27×
This company
0.62×
Market median
-266% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AUBERGINE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vivian Henningsen | Chairman | 0 companies |